These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Food, gastrointestinal pH, and models of oral drug absorption. Abuhelwa AY; Williams DB; Upton RN; Foster DJ Eur J Pharm Biopharm; 2017 Mar; 112():234-248. PubMed ID: 27914234 [TBL] [Abstract][Full Text] [Related]
5. The effect of food on drug bioavailability. Toothaker RD; Welling PG Annu Rev Pharmacol Toxicol; 1980; 20():173-99. PubMed ID: 6992698 [TBL] [Abstract][Full Text] [Related]
6. Influence of food intake on presystemic clearance of drugs. Melander A; McLean A Clin Pharmacokinet; 1983; 8(4):286-96. PubMed ID: 6352137 [TBL] [Abstract][Full Text] [Related]
7. Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. Charman WN; Porter CJ; Mithani S; Dressman JB J Pharm Sci; 1997 Mar; 86(3):269-82. PubMed ID: 9050793 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic drug interactions in anaesthetic practice. Wood M Clin Pharmacokinet; 1991 Oct; 21(4):285-307. PubMed ID: 1760901 [TBL] [Abstract][Full Text] [Related]
9. Ethanol-drug absorption interaction: potential for a significant effect on the plasma pharmacokinetics of ethanol vulnerable formulations. Lennernäs H Mol Pharm; 2009; 6(5):1429-40. PubMed ID: 19655809 [TBL] [Abstract][Full Text] [Related]
10. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib. Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875 [TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal dissolution, supersaturation and precipitation of the weak base indinavir in healthy volunteers. Rubbens J; Brouwers J; Tack J; Augustijns P Eur J Pharm Biopharm; 2016 Dec; 109():122-129. PubMed ID: 27693678 [TBL] [Abstract][Full Text] [Related]
12. Influence of food on the bioavailability of drugs. Melander A Clin Pharmacokinet; 1978; 3(5):337-51. PubMed ID: 81118 [TBL] [Abstract][Full Text] [Related]
13. Effects of erythromycin on gastric emptying, alcohol absorption and small intestinal transit in normal subjects. Edelbroek MA; Horowitz M; Wishart JM; Akkermans LM J Nucl Med; 1993 Apr; 34(4):582-8. PubMed ID: 8455074 [TBL] [Abstract][Full Text] [Related]
14. Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications. Fleisher D; Li C; Zhou Y; Pao LH; Karim A Clin Pharmacokinet; 1999 Mar; 36(3):233-54. PubMed ID: 10223170 [TBL] [Abstract][Full Text] [Related]
15. The dynamic gastric environment and its impact on drug and formulation behaviour. Van Den Abeele J; Rubbens J; Brouwers J; Augustijns P Eur J Pharm Sci; 2017 Jan; 96():207-231. PubMed ID: 27597144 [TBL] [Abstract][Full Text] [Related]
16. [Food intake and resorption of drugs from the gastrointestinal tract]. Walter-Sack I Z Gesamte Inn Med; 1991 Mar; 46(4):95-100. PubMed ID: 2058221 [TBL] [Abstract][Full Text] [Related]
17. Intestinal lead absorption in rats: effects of circadian rhythm, food, undernourishment, and drugs which alter gastric emptying and GI motility. Aungst BJ; Fung HL Res Commun Chem Pathol Pharmacol; 1981 Dec; 34(3):515-30. PubMed ID: 7323447 [TBL] [Abstract][Full Text] [Related]
18. Viscosity-mediated negative food effect on oral absorption of poorly-permeable drugs with an absorption window in the proximal intestine: In vitro experimental simulation and computational verification. Cvijić S; Parojčić J; Langguth P Eur J Pharm Sci; 2014 Sep; 61():40-53. PubMed ID: 24751672 [TBL] [Abstract][Full Text] [Related]
19. Exploring food effects on indinavir absorption with human intestinal fluids in the mouse intestine. Holmstock N; De Bruyn T; Bevernage J; Annaert P; Mols R; Tack J; Augustijns P Eur J Pharm Sci; 2013 Apr; 49(1):27-32. PubMed ID: 23402972 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of meloxicam administered as regular and fast dissolving formulations to the rat: influence of gastrointestinal dysfunction on the relative bioavailability of two formulations. Aghazadeh-Habashi A; Jamali F Eur J Pharm Biopharm; 2008 Nov; 70(3):889-94. PubMed ID: 18715548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]